Document resource
Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune liver disease, characterised by widespread inflammation and scarring in the liver, accompanied by damage to and loss of the intrahepatic bile ducts. 1 2 Over the past decade, there have been significant advances in our understanding of PBC pathophysiology, resulting in the development of better therapies, personalised medicine, introduction of risk stratification and reduced PBC stigma.1 3 4 However, there is still room to improve care of people living with PBC.